Akebia Therapeutics Inc. sell Global_Player
Start price
23.05.23
/
50%
€1.44
Target price
23.05.24
-
Performance (%)
-21.56%
End price
25.05.23
€1.13
Summary
This prediction ended on 25.05.23 with a price of €1.13. The price of Akebia Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.56%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Akebia Therapeutics Inc. | -0.266% | -0.266% | -71.776% | -35.216% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell Akebia Therapeutics Inc.